New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHGH Fragment 176-191 vs Adipotide

HGH Fragment 176-191 vs Adipotide

Side-by-side comparison of key properties, dosing, and research.

Fat Loss & Metabolic
HGH Fragment 176-191
Fat Loss & Metabolic
Adipotide
Summary
HGH Fragment 176-191 (also known as AOD-9604) is a stabilized, modified fragment of the human growth hormone molecule corresponding to amino acids 176–191 with an addition of a tyrosine residue at the N-terminus. It retains HGH's fat-burning properties without the anabolic, diabetogenic, or IGF-1-stimulating effects.
Adipotide (FTPP) is a chimeric proapoptotic peptide that selectively targets and destroys blood vessels feeding white adipose tissue. It binds prohibitin on the vasculature of fat tissue, delivering a proapoptotic sequence that induces cell death in fat-specific blood vessels, causing targeted fat tissue regression.
Half-Life
~30 minutes
Estimated 2-4 hours
Admin Route
SubQ
Subcutaneous, Intravenous (research)
Research
Typical Dose
250–500 mcg
Not established for humans; primate studies used 0.1-1 mg/kg
Frequency
1–3 times daily
Daily for 4 weeks (research protocol)
Key Benefits
  • Selective fat burning without anabolic side effects
  • Reduces visceral and subcutaneous fat
  • No insulin resistance or blood glucose disruption
  • Does not stimulate IGF-1
  • May support cartilage and bone repair (at higher doses)
  • No effect on growth or organ size
  • Targeted reduction of white adipose tissue
  • Promotes fat vasculature apoptosis without systemic toxicity
  • Demonstrated significant fat loss in primate studies
  • Potential for visceral and subcutaneous fat reduction
  • Novel non-hormonal mechanism distinct from GLP-1 agonists
  • Explored for obesity and metabolic syndrome
Side Effects
  • Injection site irritation
  • Temporary lethargy
  • Headache (rare)
  • Nausea (rare)
  • Renal toxicity observed in primate studies (transient, dose-dependent)
  • Dehydration and electrolyte imbalances in research
  • Weight regain upon cessation
  • Limited human data; side effect profile largely from animal studies
Stacks With